Abbott Laboratories (TSX:ABT)
Canada · Delayed Price · Currency is CAD 17.41
+0.21 (1.22%)
Oct 9, 2026, 3:48 PM EST
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of CAD 245.91 billion as of October 12, 2026. Its market cap has decreased by 24.59% in one year.
Market Cap
245.91B
Enterprise Value
285.53B
Revenue
66.16B
Global Rank
n/a
Country Rank
n/a
PE Ratio
32.06
ChartMarket Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 245.91B, an increase of 38,547.79%. That is a compound annual growth rate of 10.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 245.91B | -17.68% |
| Dec 31, 2025 | 298.71B | 5.82% |
| Dec 31, 2024 | 282.28B | 11.86% |
| Dec 29, 2023 | 252.36B | -2.60% |
| Dec 30, 2022 | 259.08B | -15.18% |
| Dec 31, 2021 | 305.44B | 27.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 359.12M |
| Vector Science and Therapeutics | 258.00M |
| Theralase Technologies | 54.33M |
| Cannabix Technologies | 36.95M |
| Perimeter Medical Imaging AI | 33.76M |
| Cheelcare | 31.60M |
| Conavi Medical | 20.01M |
| MedX Health | 16.40M |